期刊文献+

IMP3在食管鳞癌中高表达是独立预后因素 被引量:3

Overexpression of IMP3 is an independent prognostic factor for esophageal squamous cell carcinoma
下载PDF
导出
摘要 目的研究胰岛素样生长因子ⅡmRNA结合蛋白3(IMP3)在食管鳞癌组织中的表达及其与临床因素之间的关系。方法免疫组织化学检测100对食管鳞癌及正常食管黏膜中的IMP3蛋白表达水平。Realtime PCR检测33对食管鳞癌组织中IMP3的mRNA表达水平。结果 IMP3在癌组织中的表达显著高于癌旁正常组织(17%vs 2%,P<0.001)。IMP3的高表达与食管癌患者预后差之间显著相关(P=0.015),是独立的预后因素。IMP3的mRNA在癌组织中表达升高,但与蛋白水平之间没有相关性。结论 IMP3是食管癌患者预后因素之一。 【Objective】 To investigate the expression of insulin-like growth factor II mRNA binding protein 3(IMP3) and its relationship with clinical characteristics in esophageal squamous cell carcinoma(ESCC).【Methods】 Immunohistochemistry was performed to detect the expression level of IMP3 protein in tumor tissues and adjacent normal esophageal mucosa from 100 ESCC patients.Quantitive real time PCR was performed to detect the expression level of IMP 3 mRNA in 33 pairs of ESCC tissues.【Results】 The expression level of IMP3 protein was significantly up-regulated in ESCC tissues compared with that in the adjacent normal tissues(17% vs 2%,P 〈0.001).The overexpression of IMP3 was significantly correlated with poor prognosis of ESCC patients(P =0.015).Multivariate Cox proportional hazard regression analysis suggested IMP3 as an independent prognostic factor for ESCC patients.The mRNA level of IMP3 was also increased in ESCC tissues,but there was no correlation with protein level.【Conclusion】 IMP3 is up-regulated and functions as one of prognostic factors in ESCC patients.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2010年第23期3583-3587,共5页 China Journal of Modern Medicine
基金 国家高技术研究发展计划项目(No:2006AA020707)
关键词 胰岛素样生长因子Ⅱ mRNA结合蛋白3 食管肿瘤 预后 IMP-3 esophageal neoplasm prognosis
  • 相关文献

参考文献20

  • 1PARKIN DM, BRAY F, FERLAY J, et al. Global. cancer stalls- ties[J]. Cancer J Clin, 2005, 55(2): 74-108.
  • 2LAW SY, FOK M, CHENG SW, et al. A comparison of outcome after resection for squamous cell carcinomas and adenocarcinomas of the esophagus and cardia [J]. Stag Gynecol Obstet, 1992, 175(2): 107-112.
  • 3MCCANN J. Esophageal cancers: Changing character, increasing incidence[J]. J Natl Cancer Inst, 1999, 91(6): 497-498.
  • 4YISRAELI JK. Vickz proteins: A muhi-talented family of regula- tory RNA-binding proteins[J]. Biol Cell, 2005, 97(1): 87-96.
  • 5JIANG Z, CHU PG, WODA BA, et al. Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: A retrospective study [J]. Lancet Oncol, 2006, 7(7): 556-564.
  • 6MENTRIKOSKI M J, MA L, PRYOR JG, et al. Diagnostic utility of IMP3 in segregating metastatic melanoma from benign nevi in lymph nodes[J]. Mod Pathol, 2009, 2202): 1582-1587.
  • 7NOSKE A, FAGGAD A, WIRTZ R, et al. IMP3 expression in human ovarian cancer is associated with improved survival[J]. Int J Gynecol Pathol, 2009, 28(3): 203-210.
  • 8WALTER O, PRASAD M, LU S, et al. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associ- ated with a more aggressive phenotype[J]. Hum Pathol, 2009, 40 (11): 1528-1533.
  • 9HIMOTO T, KURIYAMA S, ZHANG JY, et al. Analyses of au- toantibodies against tumor-associated antigens in patients with hepatocellular carcinoma[J]. Int J Oncol, 2005, 27(4): 1079-1085.
  • 10LI C, ZOTA V, WODA BA, et al. Expression of a novel on- cofetal mRNA-binding protein IMP3 in endometrial carcinomas: Diagnostic significance and clinicopathologic correlations[J]. Mod Pathol, 2007, 20(12): 1263-1268.

同被引文献36

  • 1Prince SN, Foulstone EJ, Zaccheo OJ, et al. Functional evalu ation of novel soluble insulin-like growth factor(IGF)-Ⅱ- specilie ligand traps based on modified domain 11 of the human IGF2 receptor[J]. Mol Cancer Ther, 2007,6 (2): 607- 617.
  • 2Findeis-Hosey JJ, Yang Q, Spaulding BO, et al. IMP3 expression iscorrelated with histologic grade of lung adenocarcinoma [J]. Hum Pathol,2010,41(4) :477-484.
  • 3Marcoliver R, Florian R, Fritzs C, et al. IMP3 expression in lesions of the biliary tract:a marker for high-grade dysplasia and an independentprognostic faetorin bile duct carcinomas [J]. Human Pathology,2009,40(10): 1377-1383.
  • 4Jeng YM, Chang CC, Hu FC, et al. RNA-bindingprotein insulin-like growth factor Ⅱ mRNA-hinding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma[J].Hepatology, 2008,48 (4):1118-1127.
  • 5Ikenberg K, Fritzsche FR, Zuerrer-Haerdi U, et al. Insulin-like growth factor H RNAbinding protein 3(IMP3)is overexpressed in prostate cancer and orrelates with higher Gleason scores[J]. BMC Cancer,2010,10:341.
  • 6Slosar M,Vohra P,Prasad M, et al. Insulin-like growth factor mRNA binding protein 3(IMP3)is differentially expressed in benign and malignant follicular patterned thyroid tumors[J]. Endocr Pathol, 2009,20 (3) : 149-157.
  • 7Ishak KG, Anthony PP,Sobin LH,et al. Histological typ-ing of tumours of the liver[M].WHO International Histo-logical Classification of Tumours. Berlin 院 Springer Verlag,1994:1-37.
  • 8Carriaga MT,Henson DE. Liver,gallbladder,extrahepaticbile ducts,and pancreas [J]. Cancer,1995,75 (1):171-190.
  • 9Khan SA,Thomas HC,Davidson BR,et al. Cholangiocar-cinoma[J]. Lancet,2005,366(9493) : 1303-1314.
  • 10Poultsides GA,Zhu AX,Choti MA,et al. Intrahepaticcholangiocarcinoma [J]. Surg Clin North Am,2010,90(4):817-837.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部